1/9/2014 7:41:25 AM
Novartis AG (NOVN) is in talks with Merck & Co. to trade its animal-health and human vaccines businesses for the New Jersey drugmaker’s over-the-counter health-products unit, people familiar with the matter said. The swap would fit strategies at both companies -- and within the industry -- to focus on core strengths and get rid of other business lines. The two drugmakers may each trade about $5 billion in assets to do so, said one of the people, who asked not to be named because the process is private.
Help employers find you! Check out all the jobs and post your resume.
comments powered by